TP53 and lung adenocarcinoma: After adjusting for estimated ploidy and aberrant cell count, we performed comparison analyses and found that the TP53-mutated lung adenocarcinomas had a significantly higher score at all eight indices in the genome-wide analysis (Fig. 3).